OraSure Technologies, Inc. 

(Public, NASDAQ:OSUR)   Watch this stock   
Find more results for OSUR: NASDAQ
Feb 10, 2010
Q4 2009 Earnings Conference Call - 5:00PM EST - Add to calendar
Feb 10, 2010
Q4 2009 Earnings Release - 11:00AM EST - Add to calendar
Jan 12, 2010
Needham & Company 12th Annual Growth Conference
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin 8.33% -43.98%
Operating margin 8.22% -22.97%
EBITD margin - -18.50%
Return on average assets 5.78% -20.90%
Return on average equity 6.91% -25.18%
Employees 287 -

Address

220 East First Street
Bethlehem, PA 18015
United States - Map
+1-610-8821820 (Phone)
+1-610-8142937 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

OraSure Technologies, Inc. discussions

  View all discussions »

Description

Orasure Technologies, Inc. develops, manufactures, markets and sells oral fluid diagnostic products and specimen collection devices using its own oral fluid technologies, as well as diagnostic products, including immunoassays and other in vitro diagnostic tests and other medical services. The Company’s diagnostic products include tests, which are processed in a laboratory. These products are sold in the United States and internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physician’s offices, and commercial and industrial entities.

Officers and directors

Douglas G. Watson
Chairman of the Board
Age: 64
Bio & Compensation - Reuters
Douglas A. Michels
President, Chief Executive Officer, Director
Age: 52
Bio & Compensation - Reuters
Ronald H. Spair
Chief Financial Officer, Chief Operating Officer, Director
Age: 53
Bio & Compensation - Reuters
P. Michael Formica
Executive Vice President - Operations, General Manager - Cryosurgery
Age: 58
Bio & Compensation - Reuters
Stephen R. Lee Ph.D.
Executive Vice President, Chief Scientific Officer
Age: 49
Bio & Compensation - Reuters
Mark L. Kuna
Senior Vice President - Finance, Controller
Age: 45
Bio & Compensation - Reuters
Jack E. Jerrett
Senior Vice President, General Counsel, Secretary
Age: 50
Bio & Compensation - Reuters
Roger L. Pringle
Director
Age: 68
Bio & Compensation - Reuters
Ronny B. Lancaster
Director
Age: 58
Bio & Compensation - Reuters
Charles W. Patrick
Director
Age: 54
Bio & Compensation - Reuters